CRVO insider filings
CervoMed Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-19. Screen CRVO transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 4 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 1 filing by 1 insider — 100,000 shares, $152,621 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 3.
- Largest priced transaction: purchase of 76,319 shares @ $1.53 ($116,768) by ALAM JOHN J, filed 2026-11-19.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| ALAM JOHN J — CEO & President, Director, 10% owner | 1 | 2 legs · 100,000 sh · $152,621 | — | — |
| Blackburn Kelly — EVP, Clinical Development | 1 | — | — | 1 |
| De Rosch Mark — EVP, RA and GA and PgM | 1 | — | — | 1 |
| Winton Matthew — Chief Commercial and Business | 1 | — | — | 1 |
Recent insider filings — CervoMed Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-19 | 4 | ALAM JOHN J — CEO & President, Director, 10% owner | Purchase (P): 23,681 @ $1.51 · Purchase (P): 76,319 @ $1.53 | EDGAR |
| 2026-10-23 | 4 | Winton Matthew — Chief Commercial and Business | Grant/award (A): 19,100 (derivative) @ $0 | EDGAR |
| 2026-10-23 | 4 | De Rosch Mark — EVP, RA and GA and PgM | Grant/award (A): 19,100 (derivative) @ $0 | EDGAR |
| 2026-10-23 | 4 | Blackburn Kelly — EVP, Clinical Development | Grant/award (A): 19,100 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | BOGER JOSHUA S — Director, 10% owner | Purchase (P): 955,414 @ $3.14 · Purchase (P): 955,414 (derivative) · Purchase (P): 955,414 (derivative) | EDGAR |
| 2026-06-10 | 4 | ZAVRL FRANK — Director | Grant/award (A): 8,150 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Sabbagh Marwan — Director | Grant/award (A): 8,150 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Quigley David — Director | Grant/award (A): 8,150 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Poulton Jeffrey V. — Director | Grant/award (A): 8,150 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Hollingsworth Jane H — Director | Grant/award (A): 8,150 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Gregoire Sylvie — Director, 10% owner | Grant/award (A): 8,150 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | BOGER JOSHUA S — Director, 10% owner | Grant/award (A): 8,150 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | ALAM JOHN J — CEO & President, Director, 10% owner | Grant/award (A): 8,150 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Winton Matthew — Chief Commercial and Business | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Gregoire Sylvie — Director, 10% owner | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | ELDER WILLIAM ROBERT — CFO, GC & Secretary | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | De Rosch Mark — EVP, RA and GA and PgM | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Blackburn Kelly — EVP, Clinical Development | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | ALAM JOHN J — CEO & President, Director, 10% owner | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-12-05 | 4 | Quigley David — Director | Grant/award (A): 16,200 (derivative) @ $0 | EDGAR |
| 2025-11-19 | 4 | Winton Matthew — Chief Commercial and Business | Purchase (P): 3,500 @ $8.43 · Purchase (P): 1,500 @ $7.95 | EDGAR |
| 2025-11-19 | 4 | Gregoire Sylvie — Director, 10% owner | Purchase (P): 10,793 @ $8.46 · Purchase (P): 10,807 @ $8.46 | EDGAR |
| 2025-11-19 | 4 | ELDER WILLIAM ROBERT — CFO, GC & Secretary | Purchase (P): 1,000 @ $8.45 · Purchase (P): 2,500 @ $8.32 | EDGAR |
| 2025-11-19 | 4 | ALAM JOHN J — CEO & President, Director, 10% owner | Purchase (P): 10,807 @ $8.46 · Purchase (P): 10,793 @ $8.46 | EDGAR |
| 2025-11-17 | 4 | Gregoire Sylvie — Director, 10% owner | Purchase (P): 4,447 @ $7.51 · Purchase (P): 1,707 @ $7.57 · Purchase (P): 1,693 @ $7.55 | EDGAR |
| 2025-11-17 | 4 | ALAM JOHN J — CEO & President, Director, 10% owner | Purchase (P): 4,447 @ $7.51 · Purchase (P): 1,693 @ $7.55 · Purchase (P): 1,707 @ $7.57 | EDGAR |
| 2025-11-17 | 4 | Winton Matthew — Chief Commercial and Business | Purchase (P): 10,000 @ $7.57 | EDGAR |
| 2025-11-13 | 4 | Gregoire Sylvie — Director, 10% owner | Purchase (P): 5,553 @ $7.35 | EDGAR |
| 2025-11-13 | 4 | ELDER WILLIAM ROBERT — CFO, GC & Secretary | Purchase (P): 3,500 @ $7.44 | EDGAR |
| 2025-11-13 | 4 | ALAM JOHN J — CEO & President, Director, 10% owner | Purchase (P): 5,553 @ $7.35 | EDGAR |
| 2025-10-08 | 4 | Winton Matthew — Chief Commercial and Business | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | ALAM JOHN J — CEO & President, Director, 10% owner | Grant/award (A): 8,100 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | ZAVRL FRANK — Director | Grant/award (A): 8,100 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | BOGER JOSHUA S — Director, 10% owner | Grant/award (A): 8,100 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | Sabbagh Marwan — Director | Grant/award (A): 8,100 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | Poulton Jeffrey V. — Director | Grant/award (A): 8,100 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | Hollingsworth Jane H — Director | Grant/award (A): 8,100 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | Gregoire Sylvie — Director, 10% owner | Grant/award (A): 8,100 (derivative) @ $0 | EDGAR |
| 2025-05-14 | 4 | ELDER WILLIAM ROBERT — CFO, GC & Secretary | Purchase (P): 4,233 @ $8.46 | EDGAR |
| 2025-02-14 | 4 | Gregoire Sylvie — Director, 10% owner | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | ELDER WILLIAM ROBERT — CFO & GC | Grant/award (A): 27,000 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | Cobuzzi Robert Joseph Jr. — Chief Operating Officer | Grant/award (A): 27,000 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | Blackburn Kelly — SVP, Clinical Development | Grant/award (A): 27,000 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | ALAM JOHN J — CEO & President, Director, 10% owner | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-08-27 | 4 | ELDER WILLIAM ROBERT — CFO & GC | Purchase (P): 1,000 @ $18.16 | EDGAR |
| 2024-06-14 | 4 | Gregoire Sylvie — Director, 10% owner | Grant/award (A): 5,750 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Hollingsworth Jane H — Director | Grant/award (A): 5,750 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Poulton Jeffrey V. — Director | Grant/award (A): 5,750 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Sabbagh Marwan — Director | Grant/award (A): 5,750 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | ZAVRL FRANK — Director | Grant/award (A): 5,750 (derivative) @ $0 | EDGAR |
Recent 8-K events — CervoMed Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-16 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-09 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-29 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-14 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-13 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-09 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-28 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-10 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-04 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CRVO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs